Open access · CC-BY
via OpenAlex
Intermittent Fasting: A User-Friendly Method for Type 2 Diabetes Mellitus
Mahreen Saeed, M. Ben Hadj Ali, Tehreem Zehra, Saiyed Ali Haider Zaidi, Rihab Tariq
Cureus · 2021 · ▲ 16 citations
Abstract
Type 2 diabetes mellitus (T2DM) is an alarmingly rising disorder characterized mainly by insulin resistance and hyperglycemia. Due to the impairment of glucose homeostasis, most subjects present with elevated serum glucose levels, which can lead to several complications, including hospitalizations and even death. Diet quality and quantity are at the heart of its pathogenesis; hence, for the management of this condition, a technique known as intermittent fasting (IF) has been an area of interest for researchers. Different fasting regimens, including alternate-day fasting, religious fasting, and time-restricted fasting, have proven to be of strategic importance for glycemic control due to their physiologic effects. According to case studies and randomized trials, therapeutic fasting has been shown to reverse insulin resistance, resulting in the discontinuance of insulin therapy while maintaining blood sugar levels. Studies on IF have demonstrated their efficacy in glycemic control and other metabolic parameters, including reducing visceral fat and controlling inflammatory mediators and markers such as C-reactive protein (CRP) and interleukin-6 (IL-6), but control in obesity is its most significant effect as it acts as a risk factor for T2DM. Several case studies have shown a reduction in elevated hemoglobin A1c (HbA1c) levels in subjects after fasting, which some believe is due to sirtuin-6 (SIRT6) proteins. SIRT6 proteins are believed to be responsible for blood glucose homeostasis and insulin resistance reversal by increasing its sensitivity. This family of proteins is increased after fasting; hence, further research in this area will help researchers better understand its mechanism of action and potential therapeutic effects on T2DM. With an alarming increase in the incidence of T2DM around the world, a cost-effective strategy is required to control the disease with easy patient compliance, and IF might prove to be the solution.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.7759/cureus.19348
- Canonical
- link ↗
- Fetched
- 2026-07-20 MST
Cite this
APA
Saeed, M., Ali, M.B.H., Zehra, T., Zaidi, S.A.H., & Tariq, R. (2021). Intermittent Fasting: A User-Friendly Method for Type 2 Diabetes Mellitus. <em>Cureus</em>. https://doi.org/10.7759/cureus.19348
Vancouver
Saeed M, Ali MBH, Zehra T, Zaidi SAH, Tariq R. Intermittent Fasting: A User-Friendly Method for Type 2 Diabetes Mellitus. Cureus. 2021. doi:10.7759/cureus.19348.
BibTeX
@article{mahreen2021Interm,
title = {Intermittent Fasting: A User-Friendly Method for Type 2 Diabetes Mellitus},
author = {Mahreen Saeed and M. Ben Hadj Ali and Tehreem Zehra and Saiyed Ali Haider Zaidi and Rihab Tariq},
journal = {Cureus},
year = {2021},
doi = {10.7759/cureus.19348},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journal of Clinical Endocrinology & Metabolism 2002
Citation only
Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes
The Aging Male 2011
Open access · OA
Telomere length and type 2 diabetes in males, a premature aging syndrome
International Journal of Andrology 2010
Open access · OA
Type 2 diabetes mellitus and testosterone: a meta-analysis study
African Journal of Biomedical Research 2026
Open access · CC-BY
Inflammaging in Cardiovascular Disease: Emerging Mechanisms and Therapeutic Perspectives
Frontiers in Endocrinology 2026
Open access · CC-BY
Case Report: Efficacy and safety of SGLT2 inhibitors in patients with Alström syndrome: a follow-up report of two siblings from the same family
Frontiers in endocrinology 2026
Open access · OA